Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular Events.
Gema RequenaLiyuan MaTil StürmerJ Bradley LaytonJulia DiBelloPublished in: Clinical drug investigation (2020)
207595 (GlaxoSmithKline Trial registry; https://www.gsk-studyregister.com/ ).